Mounjaro Rx®

Full Product Description – Mounjaro® (Tirzepatide) Injection

Mounjaro® is a once-weekly injectable prescription medication containing tirzepatide, a breakthrough dual-action GLP-1 and GIP receptor agonist. Originally developed for type 2 diabetes, Mounjaro has shown unprecedented results in clinically significant weight loss—making it a powerful tool for adults with obesity or overweight conditions, with or without metabolic comorbidities.

Mounjaro works by mimicking two natural gut hormones: GLP-1, which reduces appetite and slows digestion, and GIP, which enhances insulin sensitivity and amplifies metabolic control. Together, these actions result in appetite suppression, better blood sugar regulation, reduced fat storage, and sustained energy.

Through Precision Health, Mounjaro is prescribed based on your unique health profile and guided by board-certified providers. Our telehealth model ensures lab-based evaluation, personalized care, and seamless delivery to your door.

Key Benefits:

• Dual-action therapy for accelerated, sustainable weight loss
• Decreases hunger, cravings, and overeating
• Improves insulin function and metabolic health
• Once-weekly injection for convenience and compliance
• Monitored by licensed providers through Precision Health’s virtual platform

Common Dosage: Starts at 2.5 mg weekly and titrated up to 15 mg as tolerated
Form: Branded pen injection (Mounjaro®)
Route: Subcutaneous (SQ)
Prescription Required: Yes
Monitoring: Periodic labs and check-ins to monitor safety, progress, and adjust dosing

‍